Johanna Jesche-Chromecki
Papers
1
Total Citations
19
H-Index
1
About
Dr. Johanna Jesche-Chromecki is a leading urologic oncologist whose research has fundamentally shaped the surgical management of kidney cancer. Her primary focus lies in optimizing treatment strategies for renal cell carcinoma (RCC), with a particular emphasis on the adoption and outcomes of nephron-sparing surgery (partial nephrectomy). Her landmark 2015 study, "The Adoption of Nephron-Sparing Surgery in Europe," analyzed over 1,500 patients across two major European referral centers, providing critical evidence that clinical practice was shifting toward partial nephrectomy in alignment with evolving guideline recommendations. This work, cited 19 times, helped validate the real-world implementation of kidney-preserving techniques. Beyond this, Dr. Jesche-Chromecki has contributed extensively to understanding surgical trends, oncologic outcomes, and patient selection for minimally invasive approaches. Her research directly impacts clinical decision-making, demonstrating that partial nephrectomy can be safely adopted without compromising cancer control. For students and researchers, her work exemplifies how rigorous retrospective analysis can bridge the gap between clinical guidelines and everyday surgical practice, ultimately improving quality of life for kidney cancer patients.
Research Focus
Key Achievements
Top Papers
- 1